NEA Management Company, LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), NEA Management Company, LLC reported 44 stock positions worth $1.6 billion. Its top holding was Arcellx (ACLX) at 16.2% of the portfolio, followed by Crispr Therapeutics (CRSP, 11.2%) and Rhythm Pharmaceuticals (RYTM, 7.8%). Compared with Q4 2023, it opened 2 new positions, sold out of 2, added to 1 and reduced 6. The biggest buy was a new position in Oric Pharmaceuticals (ORIC) and the biggest sale Geron (GERN, shares −44%).
- Most Recent 13F
- Q2 2026
- Location
- TIMONIUM, MD
- CIK
- 0001512848
- Portfolio Value
- $1.6B (Q1 2024)
- SEC Filing
- 0001012975-24-000231 ↗ filed May 15, 2024
Holdings Value
Holdings 44 stocks · $1.6B
| ACLX Arcellx Inc. | 16.17% | 3,745,262 | $260.5M | No change |
| CRSP Crispr Therapeutics AG | 11.20% | 1,587,854 | $180.4M | No change |
| RYTM Rhythm Pharmaceuticals Inc. | 7.83% | 2,909,956 | $126.1M | No change |
| SVRA Savara Inc. | 7.56% | 24,471,264 | $121.9M | No change |
| COUR Coursera Inc. | 6.72% | 12,867,769 | $108.2M | No change |
| KRRO Korro Bio Inc. | 5.99% | 1,072,936 | $96.6M | No change |
| VRNA Verona Pharma Ltd. | 5.58% | 5,108,563 | $89.9M | No change |
| GLUE Monte Rosa Therapeutics Inc. | 3.37% | 7,692,298 | $54.2M | No change |
| NN Nextnav Inc. | 3.34% | 8,189,156 | $53.9M | No change |
| CVRX CVRX Inc. | 2.68% | 2,370,542 | $43.2M | No change |
| GERN Geron Corp. | 2.62% | 12,776,409 | $42.2M | Reduce -43.9% |
| TRVI Trevi Therapeutics Inc. | 2.44% | 11,370,376 | $39.2M | No change |
| NKTX Nkarta Inc. | 2.39% | 3,568,781 | $38.6M | No change |
| CELC Celcuity Inc. | 1.68% | 1,250,001 | $27.0M | No change |
| ADAPY Adaptimmune Therapeutics-ADR | 1.68% | 17,079,778 | $27.0M | No change |
| BDTX Black Diamond Therapeutics I | 1.40% | 4,448,757 | $22.6M | No change |
| XFOR X4 Pharmaceuticals Inc. | 1.29% | 14,986,793 | $20.8M | No change |
| PHAT Phathom Pharmaceuticals Inc. | 1.29% | 1,960,169 | $20.8M | No change |
| ORIC Oric Pharmaceuticals Inc. | 1.28% | 1,500,000 | $20.6M | New |
| ZFOX Zerofox Holdings Inc. | 1.26% | 18,068,513 | $20.2M | No change |
| AUPH Aurinia Pharmaceuticals Inc. | 1.23% | 3,969,834 | $19.9M | No change |
| GOSS Gossamer Bio Inc. | 1.16% | 15,838,009 | $18.7M | No change |
| INZY Inozyme Pharma Inc. | 1.16% | 2,437,689 | $18.7M | No change |
| RGLS Regulus Therapeutics Inc. | 1.16% | 6,467,802 | $18.6M | Add +232.4% |
| NEUE Neuehealth Inc. | 1.10% | 2,726,917 | $17.7M | No change |
| DESKTOP METAL INC | 0.79% | 14,407,594 | $12.7M | No change |
| GLYCOMIMETICS INC | 0.71% | 3,835,039 | $11.5M | Reduce -19.5% |
| SGMT Sagimet Biosciences Inc. Class A | 0.67% | 2,000,275 | $10.8M | Reduce -48.0% |
| TUYA Tuya Inc. | 0.54% | 4,934,640 | $8.6M | No change |
| CSBR Champions Oncology Inc. | 0.52% | 1,713,720 | $8.4M | No change |
| RENEO PHARMACEUTICALS INC | 0.49% | 4,785,494 | $7.9M | No change |
| ALLK Allakos LLC | 0.48% | 6,147,260 | $7.7M | No change |
| BUZZFEED INC | 0.44% | 15,333,892 | $7.2M | No change |
| LXRX Lexicon Pharmaceuticals Inc. | 0.35% | 2,382,286 | $5.7M | No change |
| IVA Inventiva SA - ADR | 0.33% | 1,462,586 | $5.3M | No change |
| SYBX Synlogic Inc. | 0.32% | 2,922,772 | $5.2M | Reduce 0.0% |
| MRKR Marker Therapeutics Inc. | 0.29% | 1,071,428 | $4.6M | No change |
| AFMDQ Affimed NV | 0.15% | 442,649 | $2.3M | No change |
| SNTI Senti Biosciences Inc. | 0.10% | 4,426,151 | $1.7M | No change |
| MYND Mynd.ai Inc. | 0.10% | 3,642,711 | $1.6M | Reduce -84.6% |
| XERS Xeris Biopharma Holdings Inc. | 0.06% | 419,100 | $926K | New |
| IKENA ONCOLOGY INC | 0.05% | 570,050 | $809K | No change |
| UP Wheels Up Experience Inc. | 0.02% | 106,125 | $305K | Reduce 0.0% |
| SRFM Surf Air Mobility Inc. Com New | 0.01% | 220,209 | $186K | No change |
Portfolio Sells Q4 2023 → Q1 2024
| GERN Geron Corp. | Reduce -43.9% | 2.62% | −0.59 |
| SGMT Sagimet Biosciences Inc. Class A | Reduce -48.0% | 0.67% | −0.58 |
| SYBX Synlogic Inc. | Reduce 0.0% | 0.32% | −0.43 |
| ACRV Acrivon Therapeutics Inc. | Sold out | 0.00% | −0.09 |
| GLYCOMIMETICS INC | Reduce -19.5% | 0.71% | −0.04 |
| MYND Mynd.ai Inc. | Reduce -84.6% | 0.10% | −0.02 |
| ADXN Addex Therapeutics Ltd. | Sold out | 0.00% | −0.02 |
| UP Wheels Up Experience Inc. | Reduce 0.0% | 0.02% | −0.01 |
Portfolio Buys Q4 2023 → Q1 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 26 | $1.6B | TRVI, MBX, GLUE, CELC, SGP |
| Q1 2026 | 26 | $1.8B | ACLX, CELC, SGP, TRVI, SVRA |
| Q4 2025 | 27 | $2.0B | CELC, RYTM, ACLX, TRVI, SVRA |
| Q3 2025 | 29 | $1.8B | RYTM, ACLX, VRNA, COUR, TRVI |
| Q2 2025 | 32 | $1.3B | ACLX, VRNA, RYTM, COUR, CRSP |
| Q1 2025 | 37 | $1.3B | ACLX, VRNA, RYTM, TEM, COUR |
| Q4 2024 | 41 | $1.8B | ACLX, VRNA, TEM, RYTM, NN |
| Q3 2024 | 42 | $1.8B | ACLX, TEM, VRNA, RYTM, SVRA |
| Q2 2024 | 41 | $1.3B | ACLX, TEM, RYTM, SVRA, COUR |
| Q1 2024 | 44 | $1.6B | ACLX, CRSP, RYTM, SVRA, COUR |